| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2011 , Vol 53 , Num 3
FORMULATION AND EVALUATIONS OF EZETIMIBE NANOPARTICLES PREPARED BY CONTROLLED NANOPRECIPITATION AND TRANSFORMATION INTO SOLID DOSAGE FORM
Department of pharmaceutics, B.S.Patel Pharmacy college,Linch, Gujarat, India